Plasmodium proteasome inhibitors (MMV/Takeda/University of Melbourne)

N/A

Report date: 2025/03/20 10:10:50
NME

Base Information

Drug NamePlasmodium proteasome inhibitors (MMV/Takeda/University of Melbourne)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome inhibitors
TargetsProteasome
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New ZealandJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdUniversity Of MelbourneMedicines for Malaria Venture
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A